Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Clinical trial NCT02775851 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02775851
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-06
- Primary completion
- 2023-04-14
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.